Cargando…

Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in mice

Bortezomib, a first-in-class proteasome inhibitor, is a standard method of treatment in multiple myeloma. In the present study, the therapeutic effect of bortezomib was evaluated in an ulcerative colitis model induced by dextran sulfate sodium (DSS) in mice, and the mechanism of action was also inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Li-Hong, Fan, Yu-Jing, Li, Qing, Guan, Jing-Ming, Qu, Bo, Pei, Feng-Hua, Liu, Bing-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436237/
https://www.ncbi.nlm.nih.gov/pubmed/28487944
http://dx.doi.org/10.3892/mmr.2017.6524